These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3034323)

  • 1. Plasma renin activity and cAMP in termination of pregnancy induced by sulprostone.
    Saarikoski S; Saastamoinen J; Penttilä I; Castrén O
    Br J Obstet Gynaecol; 1987 Apr; 94(4):328-32. PubMed ID: 3034323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCG, progesterone and 17-beta-estradiol levels during extra-amniotically induced early abortion by a new prostaglandin derivative (Sulprostone).
    Nilsson S; Zador G; Nygren KG; Wide L
    Gynecol Obstet Invest; 1981; 12(4):203-10. PubMed ID: 7250783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulprostone, a synthetic PGE2 analogue in first trimester abortion. Clinical efficacy and influence on serum progesterone of different single doses.
    Larsson B; Jonasson A; Carlström K
    Gynecol Obstet Invest; 1990; 29(1):10-2. PubMed ID: 2351329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Termination of early pregnancy with RU 486 (mifepristone) in combination with a prostaglandin analogue (sulprostone).
    Swahn ML; Bygdeman M
    Acta Obstet Gynecol Scand; 1989; 68(4):293-300. PubMed ID: 2694744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological action and half life in plasma or intramuscular sulprostone for termination of second trimester pregnancy.
    Briel RC; Lippert TH
    Prostaglandins Med; 1981 Jan; 6(1):1-8. PubMed ID: 7220653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of abortifacient effect of prostaglandins: changes in the level of cyclic adenosine monophosphate in the decidual tissue of women during abortion induced with sulprostone].
    Morozova MS; Goncharova VN; Chekhranova MK; Astakhova TM; Manuilova IA
    Akush Ginekol (Mosk); 1988 Dec; (12):22-4. PubMed ID: 2853936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of sulprostone for second trimester abortions and its effects on liver and kidney function.
    Ranjan V; Hingorani V; Kinra G; Agarwal N; Pande Y
    Contraception; 1982 Feb; 25(2):175-84. PubMed ID: 7075190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dinoprostone priming of the cervix prior to termination of midgestation pregnancy with sulprostone.
    Rietberg CC; Lotgering FK; Huikeshoven FJ
    Eur J Obstet Gynecol Reprod Biol; 1995 Jun; 60(2):157-60. PubMed ID: 7641968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.
    Rodger MW; Baird DT
    Lancet; 1987 Dec; 2(8573):1415-8. PubMed ID: 2891991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin.
    Swahn ML; Bygdeman M
    Br J Obstet Gynaecol; 1988 Feb; 95(2):126-34. PubMed ID: 3349002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma renin activity in abortion.
    Soveri P; Fyhrquist F; Widholm O
    Acta Obstet Gynecol Scand; 1976; 55(2):175-7. PubMed ID: 1258623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dose-dependent effect of locally administered sulprostone gel on serum luteal and placental hormones in cervix priming in the 1st trimester].
    Rath W; Pitzel L; Hilgers R; Kuhn W
    Zentralbl Gynakol; 1989; 111(10):634-44. PubMed ID: 2750356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the concentration of alpha-fetoprotein and placental hormones following two methods of medical abortion in early pregnancy.
    Thong KJ; Norman JE; Baird DT
    Br J Obstet Gynaecol; 1993 Dec; 100(12):1111-4. PubMed ID: 7507707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of intramuscular sulprostone and vacuum aspiration for termination of early pregnancy.
    Prasad S; Kinra G; Hingorani V
    Contraception; 1985 Nov; 32(5):429-35. PubMed ID: 4085246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Menstrual induction" with Sulproston.
    Csapo AI; Peskin EG; Pulkkinen M; Laajoki V; Kivikoski A; Lampe L; Godeny S; Szeverenyi M; Herczeg J; Resch B; Bacos L
    Prostaglandins; 1982 Nov; 24(5):657-665. PubMed ID: 6298903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose prostaglandin E2 analogue for cervical dilatation prior to pregnancy termination.
    Borten M; DiLeo LA; Friedman EA
    Am J Obstet Gynecol; 1984 Nov; 150(5 Pt 1):561-5. PubMed ID: 6496588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early pregnancy-abortion model using sulprostone.
    Fleischer A; Schulman H; Blattner P; Jagani N; Fayemi A
    Prostaglandins; 1982 May; 23(5):643-55. PubMed ID: 7122906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Termination of normal and pathological pregnancy with Sulprostone.
    Fischer Z; Chwalisz K; Michałkiewicz W
    Acta Chir Hung; 1986; 27(3):151-6. PubMed ID: 3825407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating levels of placental protein 12 and chorionic gonadotrophin following RU 38486 and gemeprost for termination of first trimester pregnancy.
    Olajide F; Howell RJ; Wass JA; Holly JM; Bohn H; Grudzinskas JG; Chapman MG; Chard T
    Hum Reprod; 1989 Apr; 4(3):337-40. PubMed ID: 2715311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal plasma estradiol and progesterone levels during therapeutic abortion induced by 16, 16 dimethyl PGE2 p-benzaldehyde semicarbazone ester.
    Tan KC; Goh VH; Karim SM; Ratnam SS; Kottegoda SR
    Prostaglandins Leukot Med; 1984 May; 14(2):215-24. PubMed ID: 6588391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.